Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma

Condition:   Multiple Myeloma Intervention:   Other: Chemotherapy and/or autologous hematopoietic stem cell transplantation Sponsor:   Qilu Hospital of Shandong University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials